跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
LEVOTHOX levothyroxine sodium 150 microgram tablet blister
Approved
STANDARD
LEVOTHOX levothyroxine sodium 150 microgram tablet blister
Accord Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
23fe5c10356c54c3
Company
Accord Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
23fe5c10356c54c3
Product Name
LEVOTHOX levothyroxine sodium 150 microgram tablet blister
Artg Id
364025
Artg Name
LEVOTHOX levothyroxine sodium 150 microgram tablet blister
Sponsor
Accord Healthcare Pty Ltd
Company Detail Path
/organization/accord-healthcare-pty-ltd
Artg Date
2022-07-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01748-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
23fe5c10356c54c3
Type
Standard
Back to TGA Approvals
LEVOTHOX levothyroxine sodium 150 microgram tablet blister - TGA Drug Approval Details
